Incentive plans for any drugs proven of its efficacy equivalency.

Published: 2003-04-23 06:59:00

Updated: 2003-04-23 06:59:00

The KFDA will provide an incentive plan for any drugs that were already proved its efficacy equivalencies to the original products through not only the bio-equivalent test but also other physicochemical test or comparative dissolution tests in order to expand the ground for the substituted dispen...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK